UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation

Critical care medicine, 2004-12, Vol.32 (12), p.2416-2421

2004

Volltextzugriff (PDF)

Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests

Journal of hepatology, 2010-03, Vol.52 (3), p.355-361

2010

Volltextzugriff (PDF)

Identification and characterization of Ixodes scapularis antigens that elicit tick immunity using yeast surface display

PloS one, 2011-01, Vol.6 (1), p.e15926-e15926

2011

Volltextzugriff (PDF)

Effect of Puumala hantavirus infection on human umbilical vein endothelial cell hemostatic function: platelet interactions, increased tissue factor expression and fibrinolysis regulator release

Frontiers in microbiology, 2015-03, Vol.6, p.220-220

2015

Volltextzugriff (PDF)

Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma

Proceedings of the National Academy of Sciences - PNAS, 2010-05, Vol.107 (20), p.9083-9087

2010

Volltextzugriff (PDF)

Activation of coagulation and tissue fibrin deposition in experimental influenza in ferrets

BMC microbiology, 2014-05, Vol.14 (1), p.134-134

2014

Volltextzugriff (PDF)

Reduced ADAMTS13 activity in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

Journal of cerebral blood flow and metabolism, 2009-10, Vol.29 (10), p.1734-1741

2009

Volltextzugriff (PDF)

Reversal of factor XI targeting anticoagulants – an in vitro evaluation

Journal of thrombosis and haemostasis, 2024-01, Vol.22 (1), p.300-303

2024

Volltextzugriff (PDF)

In vitro evaluation of factor IX as novel treatment for factor XI deficiency

Blood, 2019-08, Vol.134 (6), p.573-575

2019

Volltextzugriff (PDF)

OKL-1111, A modified cyclodextrin as a potential universal reversal agent for anticoagulants

Thrombosis research, 2023-07, Vol.227, p.17-24

2023

Volltextzugriff (PDF)

Ethyl pyruvate exerts combined anti-inflammatory and anticoagulant effects on human monocytic cells

Thrombosis and haemostasis, 2006-12, Vol.96 (6), p.789-793

2006

Volltextzugriff (PDF)

Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen

Journal of thrombosis and haemostasis, 2022-11, Vol.20 (11), p.2538-2549

2022

Volltextzugriff (PDF)

Iron-Driven Alterations on Red Blood Cell-Derived Microvesicles Amplify Coagulation during Hemolysis via the Intrinsic Tenase Complex

Thrombosis and haemostasis, 2022-01, Vol.122 (1), p.80-91

2022

Volltextzugriff (PDF)

Endotoxaemia induces resistance to activated protein C in healthy humans

British journal of haematology, 2006-07, Vol.134 (2), p.213-219

2006

Volltextzugriff (PDF)

A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function

Blood, 2015-03, Vol.125 (11), p.1822-1825

2015

Volltextzugriff (PDF)

Iron-Driven Alterations on Red Blood Cell-Derived Microvesicles Amplify Coagulation during Hemolysis via the Intrinsic Tenase Complex

Thrombosis and haemostasis, 2021-06

2021

Volltextzugriff (PDF)

Factor Xa Activation of Factor V Is of Paramount Importance in Initiating the Coagulation System: Lessons From a Tick Salivary Protein

Circulation (New York, N.Y.), 2013-07, Vol.128 (3), p.254-266

2013

Volltextzugriff (PDF)

Towards Restoring Coagulation in Hemophilia By Antibody-Mediated Inhibition of Antithrombin

Blood, 2015-12, Vol.126 (23), p.550-550

2015

Volltextzugriff (PDF)

Chemical Footprinting Reveals Conformational Changes Following Activation of Factor XI

Thrombosis and haemostasis, 2018-02, Vol.118 (2), p.340-350

2018

Volltextzugriff (PDF)

Two novel inhibitory anti-human factor XI antibodies prevent cessation of blood flow in a murine venous thrombosis model

Thrombosis and haemostasis, 2013-11, Vol.110 (5), p.1065-1073

2013

Volltextzugriff (PDF)

Clot lysis phenotype and response to recombinant factor VII a in plasma of haemophilia A inhibitor patients

British journal of haematology, 2013-09, Vol.162 (6), p.827-835

2013

Volltextzugriff (PDF)

The Prothrombin Time Point of the Disseminated Intravascular Coagulation Score

Critical care medicine, 2005-06, Vol.33 (6), p.1471-1472

2005

Volltextzugriff (PDF)

On the Evaluation of the ISTH Score for Overt Disseminated Intravascular Coagulation

Critical care medicine, 2005-05, Vol.33 (5), p.1185-1186

2005

Volltextzugriff (PDF)

Clot lysis phenotype and response to recombinant factor Vila in plasma of haemophilia A inhibitor patients

British journal of haematology, 2013, Vol.162 (6), p.827-835

2013

Volltextzugriff (PDF)

Clot lysis phenotype and response to recombinant factor VIIa in plasma of haemophilia A inhibitor patients

British journal of haematology, 2013-09, Vol.162 (6), p.827-835

2013

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(69)

Sprache

Englisch
(69)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation

Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests

Identification and characterization of Ixodes scapularis antigens that elicit tick immunity using yeast surface display

Effect of Puumala hantavirus infection on human umbilical vein endothelial cell hemostatic function: platelet interactions, increased tissue factor expression and fibrinolysis regulator release

Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma

Activation of coagulation and tissue fibrin deposition in experimental influenza in ferrets

Reduced ADAMTS13 activity in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

Reversal of factor XI targeting anticoagulants – an in vitro evaluation

In vitro evaluation of factor IX as novel treatment for factor XI deficiency

OKL-1111, A modified cyclodextrin as a potential universal reversal agent for anticoagulants

Ethyl pyruvate exerts combined anti-inflammatory and anticoagulant effects on human monocytic cells

Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen

Iron-Driven Alterations on Red Blood Cell-Derived Microvesicles Amplify Coagulation during Hemolysis via the Intrinsic Tenase Complex

Endotoxaemia induces resistance to activated protein C in healthy humans

A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function

Iron-Driven Alterations on Red Blood Cell-Derived Microvesicles Amplify Coagulation during Hemolysis via the Intrinsic Tenase Complex

Factor Xa Activation of Factor V Is of Paramount Importance in Initiating the Coagulation System: Lessons From a Tick Salivary Protein

Towards Restoring Coagulation in Hemophilia By Antibody-Mediated Inhibition of Antithrombin

Chemical Footprinting Reveals Conformational Changes Following Activation of Factor XI

Two novel inhibitory anti-human factor XI antibodies prevent cessation of blood flow in a murine venous thrombosis model

Clot lysis phenotype and response to recombinant factor VII a in plasma of haemophilia A inhibitor patients

The Prothrombin Time Point of the Disseminated Intravascular Coagulation Score

On the Evaluation of the ISTH Score for Overt Disseminated Intravascular Coagulation

Clot lysis phenotype and response to recombinant factor Vila in plasma of haemophilia A inhibitor patients

Clot lysis phenotype and response to recombinant factor VIIa in plasma of haemophilia A inhibitor patients

Suchergebnisse filtern